Methotrexate (MTX) is a key anchor drug for rheumatoid arthritis (RA) management. Fibrotic interstitial lung disease (ILD) is a common complication of RA. Whether MTX exposure increases the risk of ILD in patients with RA is disputed. We aimed to evaluate the association of prior MTX use with development of RA-ILD.
Methotrexate and rheumatoid arthritis associated interstitial lung disease / Juge, Pierre-Antoine; Lee, Joyce S; Lau, Jessica; Kawano-Dourado, Leticia; Rojas Serrano, Jorge; Sebastiani, Marco; Koduri, Gouri; Matteson, Eric; Bonfiglioli, Karina; Sawamura, Marcio; Kairalla, Ronaldo; Cavagna, Lorenzo; Bozzalla Cassione, Emanuele; Manfredi, Andreina; Mejia, Mayra; Rodríguez-Henriquez, Pedro; González-Pérez, Montserrat I; Falfán-Valencia, Ramcés; Buendia-Roldán, Ivette; Pérez-Rubio, Gloria; Ebstein, Esther; Gazal, Steven; Borie, Raphaël; Ottaviani, Sébastien; Kannengiesser, Caroline; Wallaert, Benoît; Uzunhan, Yurdagul; Nunes, Hilario; Valeyre, Dominique; Saidenberg-Kermanac'h, Nathalie; Boissier, Marie-Christophe; Wemeau-Stervinou, Lidwine; Flipo, René-Marc; Marchand-Adam, Sylvain; Richette, Pascal; Allanore, Yannick; Dromer, Claire; Truchetet, Marie-Elise; Richez, Christophe; Schaeverbeke, Thierry; Lioté, Huguette; Thabut, Gabriel; Deane, Kevin D; Solomon, Joshua; Doyle, Tracy; Ryu, Jay H; Rosas, Ivan; Holers, V Michael; Boileau, Catherine; Debray, Marie-Pierre; Porcher, Raphaël; Schwartz, David A; Vassallo, Robert; Crestani, Bruno; Dieudé, Philippe. - In: EUROPEAN RESPIRATORY JOURNAL. - ISSN 0903-1936. - 57:2(2020), pp. 1-9. [10.1183/13993003.00337-2020]
Methotrexate and rheumatoid arthritis associated interstitial lung disease
Juge, Pierre-Antoine; Lee, Joyce S; Lau, Jessica; Kawano-Dourado, Leticia; Rojas Serrano, Jorge; Sebastiani, Marco ;Koduri, Gouri; Matteson, Eric; Bonfiglioli, Karina; Sawamura, Marcio; Kairalla, Ronaldo; Cavagna, Lorenzo; Bozzalla Cassione, Emanuele; Manfredi, Andreina ;Mejia, Mayra; Rodríguez-Henriquez, Pedro; González-Pérez, Montserrat I; Falfán-Valencia, Ramcés; Buendia-Roldán, Ivette; Pérez-Rubio, Gloria; Ebstein, Esther; Gazal, Steven; Borie, Raphaël; Ottaviani, Sébastien; Kannengiesser, Caroline; Wallaert, Benoît; Uzunhan, Yurdagul; Nunes, Hilario; Valeyre, Dominique; Saidenberg-Kermanac'h, Nathalie; Boissier, Marie-Christophe; Wemeau-Stervinou, Lidwine; Flipo, René-Marc; Marchand-Adam, Sylvain; Richette, Pascal; Allanore, Yannick; Dromer, Claire; Truchetet, Marie-Elise; Richez, Christophe; Schaeverbeke, Thierry; Lioté, Huguette; Thabut, Gabriel; Deane, Kevin D; Solomon, Joshua; Doyle, Tracy; Ryu, Jay H; Rosas, Ivan; Holers, V Michael; Boileau, Catherine; Debray, Marie-Pierre; Porcher, Raphaël; Schwartz, David A; Vassallo, Robert; Crestani, Bruno; Dieudé, Philippe
2020
Abstract
Methotrexate (MTX) is a key anchor drug for rheumatoid arthritis (RA) management. Fibrotic interstitial lung disease (ILD) is a common complication of RA. Whether MTX exposure increases the risk of ILD in patients with RA is disputed. We aimed to evaluate the association of prior MTX use with development of RA-ILD.
Citazione
Methotrexate and rheumatoid arthritis associated interstitial lung disease / Juge, Pierre-Antoine; Lee, Joyce S; Lau, Jessica; Kawano-Dourado, Leticia; Rojas Serrano, Jorge; Sebastiani, Marco; Koduri, Gouri; Matteson, Eric; Bonfiglioli, Karina; Sawamura, Marcio; Kairalla, Ronaldo; Cavagna, Lorenzo; Bozzalla Cassione, Emanuele; Manfredi, Andreina; Mejia, Mayra; Rodríguez-Henriquez, Pedro; González-Pérez, Montserrat I; Falfán-Valencia, Ramcés; Buendia-Roldán, Ivette; Pérez-Rubio, Gloria; Ebstein, Esther; Gazal, Steven; Borie, Raphaël; Ottaviani, Sébastien; Kannengiesser, Caroline; Wallaert, Benoît; Uzunhan, Yurdagul; Nunes, Hilario; Valeyre, Dominique; Saidenberg-Kermanac'h, Nathalie; Boissier, Marie-Christophe; Wemeau-Stervinou, Lidwine; Flipo, René-Marc; Marchand-Adam, Sylvain; Richette, Pascal; Allanore, Yannick; Dromer, Claire; Truchetet, Marie-Elise; Richez, Christophe; Schaeverbeke, Thierry; Lioté, Huguette; Thabut, Gabriel; Deane, Kevin D; Solomon, Joshua; Doyle, Tracy; Ryu, Jay H; Rosas, Ivan; Holers, V Michael; Boileau, Catherine; Debray, Marie-Pierre; Porcher, Raphaël; Schwartz, David A; Vassallo, Robert; Crestani, Bruno; Dieudé, Philippe. - In: EUROPEAN RESPIRATORY JOURNAL. - ISSN 0903-1936. - 57:2(2020), pp. 1-9. [10.1183/13993003.00337-2020]
Tutti gli autori
Juge, Pierre-Antoine; Lee, Joyce S; Lau, Jessica; Kawano-Dourado, Leticia; Rojas Serrano, Jorge; Sebastiani, Marco; Koduri, Gouri; Matteson, Eric; Bonfiglioli, Karina; Sawamura, Marcio; Kairalla, Ronaldo; Cavagna, Lorenzo; Bozzalla Cassione, Emanuele; Manfredi, Andreina; Mejia, Mayra; Rodríguez-Henriquez, Pedro; González-Pérez, Montserrat I; Falfán-Valencia, Ramcés; Buendia-Roldán, Ivette; Pérez-Rubio, Gloria; Ebstein, Esther; Gazal, Steven; Borie, Raphaël; Ottaviani, Sébastien; Kannengiesser, Caroline; Wallaert, Benoît; Uzunhan, Yurdagul; Nunes, Hilario; Valeyre, Dominique; Saidenberg-Kermanac'h, Nathalie; Boissier, Marie-Christophe; Wemeau-Stervinou, Lidwine; Flipo, René-Marc; Marchand-Adam, Sylvain; Richette, Pascal; Allanore, Yannick; Dromer, Claire; Truchetet, Marie-Elise; Richez, Christophe; Schaeverbeke, Thierry; Lioté, Huguette; Thabut, Gabriel; Deane, Kevin D; Solomon, Joshua; Doyle, Tracy; Ryu, Jay H; Rosas, Ivan; Holers, V Michael; Boileau, Catherine; Debray, Marie-Pierre; Porcher, Raphaël; Schwartz, David A; Vassallo, Robert; Crestani, Bruno; Dieudé, Philippe
Non ci sono file associati a questo prodotto.
Sei sicuro che questo prodotto debba essere cancellato?
La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. L’Università di Modena e Reggio Emilia non si assume alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione.